Article info
PDFFindings that shed new light on the possible pathogenesis of a disease or an adverse effect
Case report
Angioedema, ACE inhibitor and COVID-19
- Correspondence to Bayu Sutarjono; b.sutarjono{at}saba.edu
Citation
Angioedema, ACE inhibitor and COVID-19
Publication history
- Accepted August 25, 2020
- First published September 9, 2020.
Online issue publication
January 24, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage